glutathione peroxidase 1 have heme A Dual Role of Oxygenase-1 in Cancer Cells Post-ischemic changes in heme oxygenase

Garbage in, garbage out

than the scale as a measurement of success

The discontinuation was driven by (Bergam, 2025) (Figure 2): the availability of newer, safer & more accurate alternative testing for MG including electrophysiological & antibody tests, as well as safety concerns (bradycardia & respiratory complications) limited diagnostic reliability (with both false-positive and false-negative results) The decision to remove edrophonium as an available (alternative) diagnostic test has been challenged (Keritam et al, 2026)

Drug repurposing to discover novel ferroptosis therapeutics Drug repurposing offers a potentially expedited path to clinical trials at lower costs and reduced safety risks